Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition People and Community Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition Karren Franco April 29, 2022 London, England – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on... Read More Read more about Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition
